Nasal spray for eosinophilic asthma
Part of Blood & lymphatic, Lungs & breathing clinical trials.
This trial tests a new nasal spray (AD17002) for people with moderate to severe eosinophilic asthma, a type of asthma with high eosinophil blood cells. The spray is self-administered at home, and the study aims to see if it is safe and helps control asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had asthma for at least 6 months.
- Your asthma must be moderate to severe, meaning you need daily controller medicine.
- Your eosinophil count (a blood marker for allergic inflammation) is 150 or higher.
- You are not a current smoker and haven't quit within the last 6 months.
- You have not had a severe asthma flare-up in the last month that needed hospitalization or high-dose steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication called KT-621 for people with moderate to severe eosinophilic asthma. It aims to see if the drug can help control asthma better than the standard inhaled treatments alone.
This study looks at different types of eosinophils (a type of white blood cell) in people with asthma, EGPA, or HES. It aims to help doctors better understand these conditions and could guide future treatments.
This trial tests a nasal rinse solution for people with sinusitis and asthma-COPD overlap. It may help reduce sinus and lung symptoms.
This study looks at how eosinophils (a type of white blood cell) work in asthma, including in people who have not responded to certain biologic treatments. By joining, you may help researchers understand asthma better and potentially improve future treatments.
This trial tests a new medicine called SHR-1703 for people with eosinophilic asthma (a type of asthma with high levels of certain white blood cells). It looks at how safe the medicine is over time and if it helps control asthma attacks. You must already be using medium or high dose inhaled steroids plus another asthma medicine, and have had at least one asthma attack in the past year.
This trial tests if an investigational nasal spray (ETH47) can reduce asthma symptoms triggered by a common cold virus (rhinovirus). You will be exposed to the virus in a safe setting to see if the spray helps control your asthma.
Hear when a new Eosinophilic Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.